Serum levels of cytokines in patients with colorectal cancer: Possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis (original) (raw)

• Balkwill FR, Burke F. The cytokine network. Immunol Today 1989;9:299–304.
  Google Scholar
• O'Garra A. Interleukins and the immune system 2. Lancet 1989;I:1003–1005.
  Google Scholar
• Arai K, Lee F, Miyajima A, et al. Cytokines: Coordinators of immune and inflammatory responses. Annu Rev Biochem 1990; 59:783–836.
  Article CAS PubMed Google Scholar
• Dinarello CA. Interleukin-1 and the pathogenesis of the acutephase response. N Engl J Med 1984;311:1413–1418.
  CAS PubMed Google Scholar
• Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470–474.
  CAS PubMed Google Scholar
• Tracey KJ, Fong Y, Hesse D, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 1987;330:662–664.
  Article CAS PubMed Google Scholar
• Nijsten MWN, De Groot ER, Ten Duis HJ, et al. Serum levels of interleukin-6 and acute phase response. Lancet 1987;II:921.
  Google Scholar
• Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987;I:355–357.
  Google Scholar
• Damas P, Reuter A, Gysen P, et al. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989;17:975–978
  CAS PubMed Google Scholar
• Nishimoto N, Yoshizaki K, Tagoh H, et al. Elevation of serum interleukin-6 prior to acute phase proteins on the inflammation by surgical operation. Clin Immunol Immunopathol 1989;50: 399–401
  Article CAS PubMed Google Scholar
• Leser HG, Gross V, Scheibenbogen C, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991;101:782–785
  CAS PubMed Google Scholar
• Damas P, Ledoux D, Nys M, et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992;215:356–362
  CAS PubMed Google Scholar
• Sakamoto K, Egami H, Yoshimura R, et al. Colony-Stimulating factor producing carcinoma of the gallbladder. Jpn J Clin Oncol 1986;16:87–96
  CAS PubMed Google Scholar
• Kawano M, Hirano T, Matsuda T, et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988;332:83–85
  Article CAS PubMed Google Scholar
• Van Meir E, Sawamura Y, Diserens AC, et al. Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res 1990;50:6683–6688
  PubMed Google Scholar
• Watson JM, Sensintaffar JL, Berek JS, et al. Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res 1990;50:6959–6965
  CAS PubMed Google Scholar
• Siegall CB, Schwab G, Nordan RP, et al. Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res 1990;50:7786–7788
  CAS PubMed Google Scholar
• Takenawa J, Kaneko Y, Fukumoto M, et al. Enhanced expression of interleukin-6 in primary human renal cell carcinomas. J Natl Cancer Inst 1991;83:1668–1672
  CAS PubMed Google Scholar
• Naylor MS, Stamp GWH, Foulkes WD, et al. Tumor necrosis factor and its receptors in human ovarian cancer. J Clin Invest 1993;91:2194–2206
  CAS PubMed Google Scholar
• Scuderi P, Lam KS, Ryan KJ, et al. Raised serum levels of tumor neerosis factor in parasitic infections. Lancet 1986;II: 1364–1365
  Google Scholar
• Teppo AM, Maury CPJ. Radioimmunoassay of tumor necrosis factor in serum. Clin Chem 1987;33:2024–2027
  CAS PubMed Google Scholar
• Balkwill F, Burke F, Talbot D, et al. Evidence for tumor neerosis factor eachectin production in cancer. Lancet 1987;II: 1229–1232
  Google Scholar
• Socher SH, not detectable in patients with clinical cancer cachexia. J Natl Cancer Inst 1988;80:595–598
  CAS PubMed Google Scholar
• Fearon KCH, McMillan DC, Preston T, et al. Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg 1991;213:26–31
  CAS PubMed Google Scholar
• Japanese Research Society for Cancer of Colon and Rectum. General rules for clinical and pathological studies on cancer of colon, rectum, and anus. 4th ed. Tokyo: Kanehara Shuppan, 1985
  Google Scholar
• American Joint Committee on Cancer, Manual for staging of cancer. 3rd ed, Philadelphia: JB Lippincott, 1987
  Google Scholar
• Hermanek P, Sobin LH (eds) TNM classification of malignant tumors (International Union Against Cancer). 4th ed. Berlin: Springer, 1987
  Google Scholar
• Gross V, Andus T, Caesar I, et al. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology 1992;102:514–519
  CAS PubMed Google Scholar
• Izzo RS, Witkon K, Chen AI, et al. Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis. Am J Gastroenterol 1992;87:1447–1452
  CAS PubMed Google Scholar
• Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992; 103:1587–1595
  CAS PubMed Google Scholar
• Hyams JS, Fitzgerald JE, Treem WR, et al. Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease. Gastroenterology 1993;104: 1285–1292
  CAS PubMed Google Scholar
• Shalaby MR, Waage A, Aarden L, et al. Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol 1989;53:488–498
  Article CAS PubMed Google Scholar
• Fong Y, Tracey KJ, Moldawer LL, et al. Antibodies to cachectin/ tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteremia. J Exp Med 1989;170: 1627–1633
  Article CAS PubMed Google Scholar
• Isshiki H, Akira S, Tanabe O, et al. Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive clement in the IL-6 gene. Mol Cell Biol 1990;10:2757–2764
  CAS PubMed Google Scholar
• Matsushima K, Oppenheim JJ. Interleukin-8 and MCAF: Novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1989;1:1–12
  Article Google Scholar
• Natali P, Nicotra MR, Cavaliere R, et al. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res 1990;50:1271–1278
  CAS PubMed Google Scholar
• Tsujisaki M, Imai K, Hirata H, et al. Detection of circulating adhesion molecule-1 antigen in malignant diseases. Clin Exp Immunol 1991;85:3–8
  CAS PubMed Google Scholar
• Takada A, Ohmori K, Yoneda T, et al. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 1993;53:354–361
  CAS PubMed Google Scholar
• Dejane E, Bertocchi F, Bortolami MC, et al. Interleukin 1 promotes tumor cell adhesion to cultured human endothelial cells. J Clin Invest 1988;82:1466–1470
  Google Scholar
• Larson CG, Anderson AD, Apella E, et al. The neutrophilactivating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989;243:1464–1466
  Google Scholar
• Strieter RM, Kunkel SL, Showell HL, et al. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β. Science 1989;243:1467–1469
  CAS PubMed Google Scholar
• Paccaud JP, Shifferli JA, Baggiolini M. NAP-1/IL-8 induces upregulation of CR1 receptors in human neutrophil leukocytes. Biochem Biophys Res Commun 1990;166:187–192
  Article CAS PubMed Google Scholar
• Detmers PA, Lo SK, Olsen-Egbert E, et al. Neutrophil activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 1990;171:1152–1162
  Article Google Scholar
• Takeda A, Ohmori K, Takahashi N, et al. Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. Biochem Biophys Res Commun 1991; 179:713–719
  Article Google Scholar
• Berg EL, Robinson MK, Mansson O, et al. A carbohydrate domain common to both sialyl Lea and sialyl Lex is recognized by the endothelial cell leukocyte adhesion molecule ELAM-1. J Biol Chem 1991;266:14869–14872
  CAS PubMed Google Scholar
• Fabian I, Baldwin GC, Golde DW, et al. Biosynthetic granulocyte-macrophage colony-stimulating factor enhances neutrophil cytotoxicity toward human leukemia cells. Leukemia 1987;1:613–617
  CAS PubMed Google Scholar
• Grabstein KH, Urdal DL, Tushinski RJ, et al. Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science 1986;232:506–508
  CAS PubMed Google Scholar
• Takeda K, Hatakeyama K, Tsuchiya Y, et al. A correlation between GM-CSF gene expression and metastases in murine tumors. Int J Cancer 1991;47:413–420
  CAS PubMed Google Scholar
• Young MRI, Lozano Y, Coogan M, et al. Stimulation of the metastatic properties of Lewis lung carcinoma cells by autologous granulocyte-macrophage colony-stimulating factor. Int J Cancer 1992;50:628–634
  CAS PubMed Google Scholar
• Takeda K, Fujii N, Nitta Y, et al. Murine tumor cells metastasizing selectively in the liver: Ability to produce hepatocyteactivating cytokines interleukin-1 and/or-6. Jpn J Cancer Res 1991;82:1299–1308
  CAS PubMed Google Scholar
• Carswell EA, Old LJ, Kassel RL, et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666–3670
  CAS PubMed Google Scholar